ABOUT AVIDITY
Our mission is to profoundly improve people’s lives by delivering a new class of RNA therapeutics – AOCs. Our proprietary AOCs are designed to combine the specificity of monoclonal antibodies with the precision of oligonucleotide therapies to target the root cause of diseases previously untreatable with RNA therapeutics. Our advancing and expanding pipeline includes multiple skeletal muscle programs. We are also broadening the reach of AOCs beyond muscle tissues through both internal discovery efforts and key partnerships as the company continues to deliver on the RNA revolution.
FAQs
Where is Avidity Biosciences’ corporate headquarters?
Avidity Biosciences is headquartered at 10578 Science Center Drive
Suite 125, San Diego, CA 92121, US. The main phone number is 858-401-7900.
When was the company founded?
Avidity Biosciences was founded and commenced operations in 2012.
When did Avidity Biosciences go public?
Avidity Biosciences’ initial public offering (IPO) closed on June 16, 2020.
When is Avidity Biosciences’ fiscal year-end?
Avidity Biosciences’ fiscal year ends on December 31st.
How is Avidity Biosciences’ stock traded?
Avidity Biosciences is traded on the NASDAQ Global Market under the ticker symbol RNA, and its CUSIP number is 05370A 10 8.
Who is Avidity Biosciences’ transfer agent?
Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021
www.computershare.com
US Phone: +1 800 962 4284
International Phone: +1 781 575 312
Who are Avidity Biosciences’ independent auditors?
BDO
3570 Carmel Mountain Rd #400
San Diego, CA 92130
Who is Avidity Biosciences’ legal counsel?
Latham and Watkins LLP
12670 High Bluff Dr
San Diego, CA 92130